Chris Hill
Analyst · Johnson Rice. Please proceed
Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains and losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. So now looking at the income statement. Revenue from continuing operations was $126 million in the third quarter, up over 4% from $120.9 million in the prior quarter and up almost 7% year-over-year. The sequential increase in revenue was driven by growth in both the US and international markets. However, nice growth in the underlying operations in multiple international regions has been partially offset by the devaluation of the euro and British pound, which I will expand on later in the discussion. Additionally, although we have seen some improvement, the Ukraine-Russia conflict continues to adversely impact service revenue in the affected regions. Of this revenue, service revenue which is more international was $87.9 million for the quarter, up 3% sequentially from $85.4 million last quarter. The growth in service revenue this quarter has come from multiple international regions including some recovery from disruptions caused by the conflict in Ukraine. While underlying activity continues to grow, our international service revenue was negatively impacted by foreign currency exchange rates versus the US dollar. Using a constant US dollar, international service revenue would have been translated into an additional $1.5 million, when compared to last quarter and an additional $4.3 million when compared to Q3 of last year. The impact of these currency movements during the first nine months of 2022 was approximately $9 million compared to the same period in the prior year. Product sales, which are more equally tied to US and international activity were $38.1 million for the quarter, up over 7% sequentially and up 15% from last year. US product sales for the quarter were up over 22% sequentially and up over 13% year-over-year. Our energetic product sales into the US markets continues to be the primary driver and we're up over 19% sequentially and up over 27% year-over-year. International product sales, which are typically larger bulk orders and can vary from one quarter to another, decreased approximately 4% sequentially, but were up over 16% when compared to third quarter last year. Moving on to cost of services, ex-items for the quarter were a little below 77% of service revenue, which improved from 80% last quarter and 79% from last year. Cost of sales ex-items in the third quarter was 82% of revenue and also improved from 84% last quarter. The improvement this quarter was primarily driven by gains in manufacturing efficiencies and higher US sales. We anticipate improvement in the manufacturing absorption rate in future quarters to be in line with projected growth in product sales. G&A, ex-items for the quarter was $10 million, relatively flat compared to last quarter. G&A, ex-items is anticipated to be approximately $40 million for the full year of 2022. Depreciation and amortization for the quarter was $4.2 million and down a little from $4.4 million last quarter. EBIT, ex-items for the quarter was $13.3 million, up from $9.6 million last quarter, yielding an EBIT margin of 11% and up over 260 basis points sequentially. This quarter marked the company's highest sequential incremental margin since the COVID-19 pandemic. On a GAAP basis, EBIT was $14.6 million for the quarter. Interest expense ex-items was $2.9 million, up from $2.7 million in the last quarter. GAAP interest expense was $3.1 million, which includes writing off $210,000 of unamortized debt costs associated with renewing our credit facility during the quarter. Income tax expense ex-items at an effective tax rate of 20% was $2.1 million for the quarter and on a GAAP basis was $3.9 million for the quarter. Higher tax expense for the quarter was largely impacted by foreign currency gains primarily in the UK where unrealized foreign currency gains associated with US dollar denominated receivables are subject to tax locally. The company has taken additional steps to further mitigate this type of foreign currency risk to reduce future tax expense associated with foreign exchange rates. Effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and the impact of items discrete to each quarter. However, we continue to project the company's effective tax rate to be approximately 20%. Income from continuing operations ex-items for the quarter was $8.3 million, up $2.8 million or over 50% from the last quarter. On a GAAP basis, we recorded income from continuing operations of $7.6 million for the quarter. Earnings per diluted share from continuing operations ex-items was $0.18 for the quarter, up from $0.12 last quarter and GAAP earnings per diluted share was $0.16 for the quarter. Turning to the balance sheet. Receivables were $100.2 million and up slightly from $99.1 million in the prior quarter. Our DSOs for the third quarter were at 67 days, which improved from 69 days last quarter. Inventory was $54.8 million as of September 30th, up approximately $2.2 million from last quarter end. Inventory turns for the quarter were at 2.3 compared to 2.4 in the last quarter. As previously highlighted, the company continues to experience an increase in cost that go into inventory. Additionally challenges in the supply chain persists, so we continue to carry a larger amount of the inventory to help mitigate disruptions. We anticipate inventory turns will remain at similar levels with some improvement as we progress through the remainder of 2022 and into 2023. On the liability side of the balance sheet, our long-term debt was $185 million at the end of the third quarter. And considering cash of $14 million, net debt was $171 million, or a slight decrease from last quarter. At September 30th, our leverage ratio improved slightly and was 2.42 compared to 2.47 at last quarter end. We are projecting our leverage ratio to continue improving through year-end with a more significant improvement in the first quarter of 2023. Our debt is currently comprised of our senior notes at $135 million, as well as $50 million outstanding under our bank revolving credit facility. Looking at cash flow, for the third quarter of 2022, cash flow from operating activities was $5.8 million. And after paying for $2.7 million of CapEx in the quarter, our free cash flow was $3.1 million or up $5.7 million from the last quarter. We expect the growth in working capital to moderate cash from operations to strengthen and for the company to generate positive free cash flow in future quarters. We will continue managing capital expenditures to be in line with activity levels for the remainder of 2022. For the full year of 2022, we expect capital expenditures to be in the range of $11 million to $12 million. Core will continue its strict capital discipline and asset light business model with capital expenditures primarily targeted at growth opportunities and operating efficiency initiatives. Core Lab's operational leverage continues to provide for the ability to grow revenue and profitability with minimum capital requirements. Capital expenditures have historically ranged from 2.5% to 4% of revenue even during periods of significant growth. That same level of laboratory infrastructure, intellectual property and leverage exists in the business today. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing and projecting company's financial results particularly for those shareholders who utilize discounted cash flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.